LLLyudmila Viktorovna Lomtatidze

Lyudmila Viktorovna Lomtatidze

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lyudmila Viktorovna Lomtatidze has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Antigen-presenting subsets of neutrophils: A diagnostic marker of clinical efficiency of immunomodulatory therapy with synthetic thymic hexapeptide in children with acute hematogenous osteomyelitis

    by I. V. Nesterova, G. A. Chudilova, N. K. Barova, A. D. Safontseva, E. A. Poezzhaev, S. V. Kovaleva, V. N. Chapurina, E. A. Chicherev, Yu. V. Teterin, L. V. Lomtatidze, et al.

    The multiple functions of neutrophilic granulocytes (NG) are associated with various subsets and phenotypes of these cells. Previously, in children with severe purulent inflammatory diseases, a correlation was found between the severity of disease and contents of CD66b + CD16 + CD33 + HLA-DR + NG (APC-NG) subset. Thus, the determination of the APC-NG subset may serve as a valuable diagnostic tool and an efficiency index during complex therapy in severe purulent-inflammatory diseases. Our goal was to assess the dynamic changes in APC-NG levels in children with AHO in comparison with the dynamics of indicators of clinical effectiveness during immunomodulatory therapy with a synthetic thymic hexapeptide (HP). Materials and methods. The study group (SG) included 15 children aged 10-15 years with acute hematogenic osteomyelitis (AHO), the comparison group (CG) consisted of 13 conditionally healthy children. The contents of NG expressing CD66b, CD16, CD33, HLA-DR (FC500, Beckman Coulter), and expression density of these molecules was evaluated in peripheral blood (PB) of patients and controls. The PB samples were collected before surgery, on the 10 th day of therapy, and before discharge. The immunological parameters of control samples were studied once. The amounts of APC-NG were found to be increased by 18 times in study group before treatment, being decreased by 1.9 times on the 10 th day after the beginning of treatment, and by 3.8 times at the time of discharge (20-25 th day). However, the content of APC-NG after treatment did not reach the CG levels. Moreover, a decreased number of APC-NG correlated with positive clinical dynamics: there was an earlier regression of general and local symptoms. A delay in positive changes of APC-NG was observed in the absence of clinical efficiency, thus requiring a revision of therapeutic strategy, and changes of antibacterial therapy. Conclusion: The study demonstrated high clinical efficacy of thymic HP in the complex treatment of children with AHO and a diagnostic potential of the APC-NG contents as a diagnostic marker for monitoring efficacy of postsurgical treatment of pediatric AHO patients. This marker may also serve as a tool that allows for timely correction of AHO treatment at the in- and outpatient stages.

  • Thymus and thymic peptides: stages of the long road from experimental research to implementation in clinical practice (review)

    by I.V. Nesterova, L.V. Lomtatidze, G.A. Chudilova, S.V. Kovaleva, V.N. Chapurina, S.N. Pikturno

    Peptides isolated from the thymus and synthesized thymomimetics, due to their rich spectrum of multivariate effects, are unique structures that implement mutual feedback between the nervous, immune and endocrine systems through intercellular interactions and intracellular signaling pathways. This review not only focuses on the clinical effectiveness of using these substances to reconstruct the immune system, but also attempts to summarize the current knowledge about the mechanisms of thymic factors. Thus, the search for immunomodulators as an alternative therapeutic strategy for balancing the body’s response to excessive inflammation at the immune depression led to the discovery of previously unknown mechanisms of action of the thymic synthetic pentapeptide TP5. Our experience with synthetic thymomimetics in vitro experiments and clinical practice for various secondary immunodeficiency (SID) conditions is presented. We have proven the fact of restoration of the immune system in infectious and inflammatory diseases against the background of restoration of the functional capacity of neutrophilic granulocytes when using synthetic thymic hexapeptide (HP), which is an analogue of the active center of thymopoietin. A personalized approach to patient management with the identification of the pathological immunophenotype of SID justifies the use of synthetic thymomimetics and makes their use promising. There is no doubt that understanding the subtle mechanisms of the multi-vector action of thymic immunomodulators, demonstrated in the article, can become a point of support in determining the optimal treatment strategy for various pathologies, especially in immunosenescence, as well as immune-dependent diseases associated with atypical infectious and inflammatory processes.

  • Open Access

    Combined immunodeficiency in elderly persons with COPD as a manifestation of immune aging

    by Anna I. Pirogova, L. V. Lomtatidze, E. F. Filippov

    The study of immune system (IS) functions in chronic respiratory pathology is especially relevant in elderly and senile persons, since frequent prolonged exacerbations of chronic obstructive pulmonary disease (COPD) significantly affect the condition of patients, leading to decompensation of diseases. The objective of this study was to perform expanded evaluation of IS state, and to specify the variants of disorders in elderly and senile patients with COPD. 10 patients aged 60-80 years with COPD comprised the study group (SG) l; the comparison group (CG) included 30 conditionally healthy individuals. The general and local clinical status was determined. Before treatment, the following immune parameters were studied: T lymphocytes (CD3+CD19-, CD3+CD4+, CD3+CD8+), B lymphocytes (CD3-CD19+), NK cells (CD3-CD16+CD56+), two subsets of neutrophilic granulocytes (NG) CD64-CD32+CD16+CD11b+ and CD64+CD32+CD16+CD11b+ using an FC-500 Beckman Coulter device, with calculation of the CING index reflecting the ratio between the two NG subpopulations. Phagocytic function of NG was evaluated, i.e., engulfment (%PAN, PN, PI), killing and digestion (%D, ID) of microbial particles (S. aureus, strain 209), as well as NADPH oxidase activity by the NBT test. The SG patients showed combined immunodeficiency of varying severity: quantitative deficiency of T lymphocytes due to a decrease of T helper cells (p 0.05), altered effector function of NG (deficiency of actively phagocyting NG, impaired capture, digestion and killing, p1-3 0.05). A decrease in the CD64-CD32+CD16+CD11b+NG subset, and an 8.9-fold increase in “immature” subset (negatively transformed CD64+CD32+CD16+CD11b+) were shown, suggesting an inferior NG response to bacterial infection. When calculating the CING, bacterial infections were detected: Mild, moderate and severe conditions were diagnosed, respectively, in 60%, 10% and 30% of SG patients. The evidence of immunodeficiency in elderly and senile COPD patients has been obtained, thus requiring development of immunotherapeutic approaches aimed at recovery of IS defects, in order to increase the efficiency of COPD therapy and improve the quality of life in patients.


  • Open Access

    Cellular and humoral mechanisms of immune aging

    by Irina Vadimovna Nesterova, Svetlana Valentinovna Kovaleva, Galina Anatolyevna Chudilova, Elisey Andreyevich Poezzhaev, Anna Ivanovna Pirogova, Valeria Nikolayevna Chapurina, Lyudmila Viktorovna Lomtatidze, Yuriy Valerievich Teterin, Svetlana Nikolaevna Pikturno, Anastasia Dmitriyevna Safontseva

    Despite significant advancements in extending average life expectancy, challenges persist in enhancing the quality of life for elderly and senile individuals, preventing and treating age-associated diseases and managing geriatric syndromes. The immune system plays a crucial role in aging, undergoing extensive functional changes collectively referred to as immunosenescence. Cellular aging within the immune system is associated with telomere shortening, proteostasis loss, mitochondrial dysfunction, DNA damage, and oxidative stress. Senescent cells are characterized by resistance to apoptosis, cell cycle arrest, and abnormal production of pro-inflammatory cytokines, leading to chronic low-grade inflammation. Concurrently, the effector mechanisms of the immune response become depleted, resulting in a reduced ability of the immune system to adequately respond to antigenic stimuli. Thymic atrophy, depletion of bone marrow niches, a shift in hematopoiesis toward the myeloid lineage, and alterations in lymphocyte subpopulation ratios occur. Additionally, the effector functions of neutrophil granulocytes are impaired. However, the nature of these functional changes in immunosenescence remains insufficiently studied, requiring further research to determine the specific dysfunctions of neutrophil granulocytes in aging.


  • Open Access

    Clinical and immunological efficacy of immunomodulating hexapeptide associated with the restoration of CD11b+CD64-CD32+CD16+ and CD11b+CD64+CD32+CD16+ neutrophil granulocytes subset in women with chronic infectious and inflammatory diseases of the pelvic organs

    by Svetlana V. Kovaleva, I. V. Nesterova, G. A. Chudilova, S. N. Pikturno, L. V. Lomtatidze

    Failure of anti-infectious immune protection is considered a reason for the prolonged course and recurrence of chronic infectious and inflammatory diseases of pelvic organs (PID). Our aim was to evaluate the effect of an original hexapeptide (HP) on negatively altered subpopulations of neutrophil granulocytes (NG) CD11b+CD64-CD32+CD16+ and CD11b+CD64+CD32+CD16+, their phenotype and associated effector functions in immunocompromised women with PID. 35 women (20-40 years old) with PID were studied during the period of clinical exacerbation (study group 1, SG1). Study group 1a (SG1a) consisted of patients who underwent treatment including the HP injections (45 mcg/ mL, 1 ml intramuscularly once a day for 10 days). The comparison group (CG) consisted of 20 conditionally healthy women. The numbers of CD11b+CD64-CD32+CD16+NG and CD11b+CD64+CD32+CD16+NG cell subsets and the density of receptor expression, phagocytic and microbicidal function of NG were determined. In SG1, decreased counts of the major NG subpopulation (CD11b+CD64-CD32+CD16+NG) was revealed (p 0.05), with a trend for increase of minor subset CD11b+CD64+CD32+CD16+NG (p 0.05). In the CD11b+CD64-CD32+CD16+NG subset, we noted a decreased expression of CD16 (1.4-fold), CD11b (2-fold) (p1, 2 0.05). In the minor subset CD11b+CD64+CD32+CD16+NG, the expression densities were decreased in CD16 (1.7-fold), CD11b (2.1-fold, p1, 2 0.05). At the same time, the phagocytic and microbicidal functions of NG were found to be decreased. In the course of immunomodulatory therapy with the HP-based drug, positive changes in immunological parameters were revealed. In SG1a, an increased number of major NC subset was observed, with an increase in the expression density of CD16 by 1.2 times, CD11b by 1.7 times relative to SG1 (p1, 2 0.05). The contents of minor NG subset tended to decrease, along with CD16 expression density reaching the indices of comparison group. CD11b increased 1.3 times relative to SG1 (p 0.05). Higher ratios of actively phagocytizing NG and their killing ability have been registered. Clinically, we observed faster regression of clinical PID exacerbation symptoms and decreased frequency of relapses 6 months after treatment in 88.6% of cases. The positive immunomodulatory effects of the HP-based drug upon altered subsets of CD11b+CD64-CD32+CD16+ and CD11b+CD64+CD32+CD16+ NGs, their phenotype and associated effector functions suggest an opportunity of its usage for the correction of NG dysfunctions in immunocompromised women with PID, thus providing stable clinical and immunological remission and protective effect.


  • Open Access

    The effectiveness of immunomodulatory therapy with a synthetic analogue of the active center of the hormone thymus thymopoietin in the complex treatment of immunocompromised women with chronic infectious and inflammatory diseases of the pelvic organs

    by Svetlana V. Kovaleva, Irina V. Nesterova, Svetlana N. Pikturno, Galina A. Chudilova, Lyudmila V. Lomtatidze, Yuri V. Teterin, Anna I. Pirogova, Natalia S. Prosolypova, Аlla M. Chulkova, Ломатидзе Людмила Викторовна, et al.

    Chronic inflammatory diseases of the pelvic organs (pelvic inflammatory disease, PID) in women is among the main understudied problems in gynecology worldwide with adverse medical and socio-economic consequences, thus justifying the need for further study of immunopathogenesis and development of new approaches to treatment. Our objective was to develop new immunotherapeutic approaches to correction of combined disorders of the immune system functioning in immunocompromised women with PID and to evaluate their clinical and immunological efficacy. 55 women aged 20-40 years were examined, i.e., 35 patients with exacerbation of sluggish or recurrent PID, resistant to conventional therapy. Testiung was performed before complex treatment (study group 1 GI- 1) and after the course (study group 2 GI-2). Contents of T and B lymphocytes, natural killer cells (NK) (CYTOMICS FC500, USA), phagocytic and microbicidal functions of neutrophilic granulocytes (NG) were assessed in SG-1 and SG-2 before and 2-3 days after complex treatment with addition of an immunotherapeutic drug based on hexapeptide (HP) at a daily dose of 45 mg/ml intramuscularly for 10 days. In patients from SG-1, a decrease in T cells (CD3+CD19- ) and B cells (CD3-CD19+), a 2-fold increase in the content of NK CD3-CD16+CD56+ was found, along with altered functioning of NG (deficiency of actively phagocytizing NG, a decrease in their digestive function and NADPH-oxidase activity). In SG-2 patients, the treatment was followed by restoration of the T (CD3+CD19-) and B cells (CD3-CD19+), NK cells (CD3-CD16+CD56+), like as an increase in effector functions, i.e., microbial capture by NG and their killing ability due to activation of NADPH oxidases and normalization of microbicidal reserve capacity in the NG cell population. Positive clinical effect included reduction of clinical symptoms in acute period, absence of PID exacerbations over follow-up for 6 months (85.6% of cases). Occasional exacerbations of PID were associated with medical manipulations (5.7%) and unprotected sexual contacts (5.7%). The immunopathogenetically proven approach to correction of combined functional impairment of immune system in the women with PID shows a positive clinical and immunological effect.


  • Open Access

    Effects of intravenous immunoglobulin on the negatively transformed subpopulations of neutrophilic granulocytes in newborns with congenital pneumonia and neonatal sepsis

    by I. V. Nesterova, S. V. Kovaleva, G. A. Chudilova, L. V. Lomtatidze, T. V. Smerchinskaya, V. N. Chapurina

    Today, the diagnosis and treatment of severe infectious and inflammatory diseases in newborns, e.g., congenital pneumonia (CP) and neonatal sepsis (NS), present difficult problems. Searching sensitive and specific severity markers of bacterial inflammatory process as well as early and effective treatment are crucial for the outcome and prognosis of these life-threatening diseases. The aim of our study was to assess the effects of intravenous immunoglobulin (IVIG) injections on the negatively transformed subpopulations of neutrophilic granulocytes (NG) СD64-CD16+СD32+СD11b+, СD64+CD16+СD32+СD11b+ and evaluation of their functional activity in newborns with CP and NS. We have observed 38 full-term newborn patients. Group 1 included 19 infants with CP, including 11 children who received conventional therapy and IVIG (group 1.1), and 8 children treated at conventional protocols (group 1.2). Group 2 included 19 children with NS, including 12 children who underwent conventional therapy and IVIG treatment (group 2.1), and 7 children who were subject to conventional therapy (group 2.2). The comparison group consisted of 22 healthy full-term newborns. Testing of NG population included the following parameters: counting the numbers of NG subpopulations which simultaneously expressed CD11b CD64, CD32, CD16, as well as their phenotypic patterns, with regard of the receptor expression density (MFI) using flow cytometric techniques. Moreover, we determined phagocytic and microbicidal activity of the granulocytes. We have revealed negative transformation of СD64-CD16+СD32+СD11b+ and СD64+CD16+СD32+СD11b+ subpopulations of neutrophilic granulocytes in newborns with CP and NS, The diagnostic significance of increased СD64+CD16+СD32+СD11b+NG subpopulation was more pronounced with increasing severity of bacterial infection and inflammatory process, i.e., 18.7-fold in CP, 52.3-fold in NS, along with predominant decrease in expression of appropriate membrane receptors. These phenotypic changes were associated with impaired phagocytic and killing activity of NG. The effect of IVIG on the impaired mechanisms of antibacterial immunity is associated not only with alleviation of IgG deficiency, but also with positive remodeling of negatively transformed subpopulations of СD64-CD16+СD32+СD11b+NG and СD64+CD16+СD32+СD11b+NG, improved effector functions of NG, especially in cases of CP. Thus, following IVIG treatment, a reduced number of СD64-CD16+СD32+СD11b+NG subpopulations was fully recovered in CP, while it increased 1.5 times in NS, and the content of diagnostically significant СD64+CD16+СD32+СD11b+NG subpopulation showed a significantly decrease, both in CP (2-fold) and in NS (2.6-fold). However, this index remained higher than the content of this subpopulation in healthy newborns. At the same time, we have noted the restorative or modulatory effects by changing density of trigger molecules in NG subpopulations. Limitation of the negative NG transformation in their functionally significant subpopulations in newborns with CAP and NS was accompanied by positive clinical effects, i.e., optimization of antibiotic therapy, reduced duration of treatment, and improved mortality rates.


  • Defects in the interferon system associated with a deficiency of natural killers and T-cells in patients with COVID-19

    by I.V. Nesterova, V.N. Gorodin, G.A. Chudilova, V.N. Chapurina, V.A. Matushkina, L.V. Lomtatidze, Т.а. Semenenko, V.V. Malinovskaya, A.N. Shuvalov, E.N. Vyzhlova

    Identification of interrelated innate and sensitive immune responses in COVID-19 is an important step in the development of targeted therapeutic approaches, which is relevant. Objective. To clarify the features of the defect in the function of NK cells, T lymphocytes, the interferon system in patients with moderate and severe COVID-19. Patients and methods. Tests of the peripheral blood of 50 COVID-19 patients aged 61(57–71) and having the moderate and severe disease were performed. The following parameters were measured: the quantity of CD3+CD19–, CD3+CD4+, CD3+CD8+ T lymphocytes, NK – (CD3–CD16+CD56+), and TNK – CD3+CD16+CD56+ with expression density considered membrane receptors (MFI) (FC 500 Beckman Coulter, USA), the levels of IFN-α, IFN-γ, IL-6, TNF-α cytokines (IFA). Results. Combined immunodeficiency associated with quantitative and functional defects in NK, T lymphocytes and their subsets was revealed in moderate and severe COVID-19. An imbalance of cytokines has been established: blockade of the production of IFN-α and IFN-γ against the background of a significant increase in IL-6 and TNF-α, which negatively affects both the number and functionality of the participants in the immune response and is associated with a severe course and poor prognosis of COVID-19. Conclusion. The data obtained demonstrate the need to develop new strategies and tactics for the treatment of COVID-19, including replacement systemic therapy with recombinant IFN-α2b in combination with antioxidants (Viferon®) in adequate therapeutic doses, aimed at restoring the normal functioning of T lymphocytes, NK and the interferon system. Key words: COVID-19, interferons, moderate and severe disease course, NK cells, T lymphocytes

  • Differentiation of immunomodulatory effects of arginyl-alpha-aspartyl-lysyl-valyl-tyrosyl-arginine and glucosaminylmuramyldipeptide on effector functions and phenotype of functionally signifi cant subpopulations of neutrophilic granulocytes in an experimental model of viral-bacterial coinfection

    by I.V. Nesterova, G.A. Chudilova, V.N. Chapurina, S.V. Kovaleva, V.A. Tarakanov, Yu.V. Teterin, L.V. Lomtatidze, A.I. Pirogova

    Дифференцированность иммуномодулирующих эффектов аргинил-альфа-аспартил-лизил-валил-тирозил-аргинина и глюкозаминилмурамилдипептида на эффекторные


  • DIFFERENTIATED TRANSFORMATION OF THE PHENOTYPE OF SUBPOPULATIONS OF NEUTROPHILIC GRANULOCYTES IN VIRAL-VIRAL AND PURULENT BACTERIAL INFECTIONS IN IMMUNOCOMPROMETED CHILDREN

    by I.V. Nesterova, G.A. Chudilova, S.V. Kovaleva, V.N. Pavlenko, L.V. Lomtatidze, V.A. Tarakanov, N.K. Barova

    Облако Mail.ru - это ваше персональное надежное хранилище в интернете.